OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis
Andrew Blauvelt, Leon Kircik, Kim Papp, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1, pp. 137-146
Open Access | Times Cited: 14
Andrew Blauvelt, Leon Kircik, Kim Papp, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1, pp. 137-146
Open Access | Times Cited: 14
Showing 14 citing articles:
Topical anti-inflammatory treatments for eczema: network meta-analysis
S. Lax, Eleanor Van Vogt, Bridget Candy, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Closed Access | Times Cited: 8
S. Lax, Eleanor Van Vogt, Bridget Candy, et al.
Cochrane library (2024) Vol. 2024, Iss. 8
Closed Access | Times Cited: 8
Topical Treatments in Atopic Dermatitis: An Expansive Review
Michelle Lazar, Aurore D. Zhang, Neelam A. Vashi
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2185-2185
Open Access | Times Cited: 5
Michelle Lazar, Aurore D. Zhang, Neelam A. Vashi
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2185-2185
Open Access | Times Cited: 5
Therapeutic efficacy and safety of topical ruxolitinib in mild-to-moderate atopic dermatitis: a systematic review
Cíntia Bassani, Grazia Pertile, Sérgio Souza da Cunha, et al.
Deleted Journal (2025), pp. 100032-100032
Open Access
Cíntia Bassani, Grazia Pertile, Sérgio Souza da Cunha, et al.
Deleted Journal (2025), pp. 100032-100032
Open Access
The future of topical JAK inhibitors in the treatment of atopic dermatitis
Joanna Mazgaj, Magdalena Kotewicz, Andrzej Jaworek, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Joanna Mazgaj, Magdalena Kotewicz, Andrzej Jaworek, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
Lawrence F. Eichenfield, J. Z. Liu, Simran Marwaha, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 3, pp. 685-696
Open Access | Times Cited: 4
Lawrence F. Eichenfield, J. Z. Liu, Simran Marwaha, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 3, pp. 685-696
Open Access | Times Cited: 4
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis
Sheridan M. Hoy
American Journal of Clinical Dermatology (2022) Vol. 24, Iss. 1, pp. 143-151
Open Access | Times Cited: 16
Sheridan M. Hoy
American Journal of Clinical Dermatology (2022) Vol. 24, Iss. 1, pp. 143-151
Open Access | Times Cited: 16
Current and emerging drugs for the treatment of pruritus: an update of the literature
Rami H. Mahmoud, Sarah G Brooks, Gil Yosipovitch
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 655-672
Closed Access | Times Cited: 2
Rami H. Mahmoud, Sarah G Brooks, Gil Yosipovitch
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 655-672
Closed Access | Times Cited: 2
Prevalence and proportion by age and sex of chronic health conditions in a large healthcare system
Naomi Gronich, Walid Saliba, Janice B. Schwartz
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308031-e0308031
Open Access | Times Cited: 1
Naomi Gronich, Walid Saliba, Janice B. Schwartz
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308031-e0308031
Open Access | Times Cited: 1
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies
Eric L. Simpson, Matthias Augustin, Diamant Thaçi, et al.
American Journal of Clinical Dermatology (2024)
Open Access | Times Cited: 1
Eric L. Simpson, Matthias Augustin, Diamant Thaçi, et al.
American Journal of Clinical Dermatology (2024)
Open Access | Times Cited: 1
Recalcitrant lichen planus pigmentosus treated with topical ruxolitinib
Hannah Cornman, Elena Wei, Jaya Manjunath, et al.
JAAD Case Reports (2023) Vol. 42, pp. 84-86
Open Access | Times Cited: 3
Hannah Cornman, Elena Wei, Jaya Manjunath, et al.
JAAD Case Reports (2023) Vol. 42, pp. 84-86
Open Access | Times Cited: 3
Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy
Eric L. Simpson, Leon Kircik, Andrew Blauvelt, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 12, pp. 1523-1530
Open Access | Times Cited: 2
Eric L. Simpson, Leon Kircik, Andrew Blauvelt, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 12, pp. 1523-1530
Open Access | Times Cited: 2
The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
Deesha Desai, Ambika Nohria, Kristen Lo Sicco, et al.
JAAD Case Reports (2024) Vol. 50, pp. 141-143
Open Access
Deesha Desai, Ambika Nohria, Kristen Lo Sicco, et al.
JAAD Case Reports (2024) Vol. 50, pp. 141-143
Open Access
Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology
Johannes Ring
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 9-12
Open Access | Times Cited: 1
Johannes Ring
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 9-12
Open Access | Times Cited: 1
